Grufity logoGrufity logo

Invitae Corp Stock Research

NVTA

1.29USD0.00(0.00%)Delayedas of 27 Mar 2023, 02:00 pm

Market Summary

USD1.290.00
Delayedas of 27 Mar 2023, 02:00 pm
0.00%

NVTA Alerts

NVTA Stock Price

NVTA RSI Chart

NVTA Valuation

Market Cap

316.8M

Price/Earnings (Trailing)

-0.1

Price/Sales (Trailing)

0.61

EV/EBITDA

-0.02

Price/Free Cashflow

-0.58

NVTA Price/Sales (Trailing)

NVTA Profitability

Operating Margin

19.18%

EBT Margin

-610.34%

Return on Equity

-3.1K%

Return on Assets

-158.96%

Free Cashflow Yield

-172.45%

NVTA Fundamentals

NVTA Revenue

Revenue (TTM)

516.3M

Revenue Y/Y

-2.91%

Revenue Q/Q

-8.3%

NVTA Earnings

Earnings (TTM)

-3.1B

Earnings Y/Y

51.34%

Earnings Q/Q

66.86%

Price Action

52 Week Range

1.189.18
(Low)(High)

Last 7 days

-7.2%

Last 30 days

-37.4%

Last 90 days

-28.7%

Trailing 12 Months

-84.3%

NVTA Financial Health

Current Ratio

6.41

NVTA Investor Care

Shares Dilution (1Y)

7.65%

Diluted EPS (TTM)

-17.25

Peers (Alternatives to Invitae)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
279.9B
58.1B
4.88% 1.38%
23.64
4.82
3.30% 2.55%
87.7B
12.2B
9.61% 20.63%
20.21
7.2
-24.26% -46.28%
80.8B
8.9B
6.80% 24.91%
24.32
9.05
17.91% 41.84%
15.6B
3.4B
-10.55% -10.18%
45.92
4.61
13.67% -64.09%
MID-CAP
6.3B
820.2M
18.24% 39.36%
-11.51
7.68
31.13% -16.13%
2.6B
278.3M
-26.06% -48.44%
-16.69
9.26
92.72% 15.56%
SMALL-CAP
1.6B
296.5M
-8.08% -20.51%
-43.24
5.33
35.09% 51.62%
597.7M
137.0M
-4.54% -49.04%
-8.9
4.36
45.65% -114.55%
479.1M
321.8M
-36.12% -76.84%
-6.25
1.49
8.57% -149.86%
316.8M
516.3M
-37.38% -84.33%
-0.1
0.61
12.13% -719.59%
247.4M
450.9M
-24.70% -74.25%
15.93
0.55
-3.52% -83.51%
142.1M
-
-18.72% 19.47%
-4
-
- -39.92%
3.6M
3.3M
31.86% 93.51%
-0.11
1.09
-21.77% 4.40%

Financials for Invitae

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-0.7%516,303,000519,970,000500,829,000480,519,000460,449,000
  S&GA Expenses-6.6%218,881,000234,291,000240,599,000234,814,000225,910,000
  R&D Expenses-13.0%402,088,000462,323,000472,657,000463,965,000416,087,000
EBITDA4.0%-2,952,379,000-3,074,270,000-2,995,039,000-400,734,000-
EBITDA Margin3.3%-5.72-5.91-5.98-0.83-
Earnings Before Taxes3.3%-3,151,197,000-3,258,800,000-3,160,600,000-516,350,000-415,863,000
EBT Margin2.6%-6.10-6.27-6.31-1.07-
Interest Expenses1.0%56,747,00056,180,00056,104,00055,492,00049,900,000
Net Income3.3%-3,106,293,000-3,211,600,000-3,108,620,000-451,373,000-379,006,000
Net Income Margin2.6%-6.02-6.18-6.21-0.94-
Free Cahsflow16.5%-546,270,000-654,424,000-694,738,000-686,975,000-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets-3.6%1,9542,0262,2914,7684,920
  Current Assets-5.0%6937308941,0311,179
    Cash Equivalents18.6%257217304325923
  Inventory1.6%30.0030.0049.0043.0034.00
  Net PPE-4.5%109114133130115
  GoodwillNaN%---2,2832,283
Liabilities-0.8%1,8521,8671,9051,9241,941
  Current Liabilities-4.6%108113139168144
Shareholder's Equity-35.9%1021593862,8442,978
  Retained Earnings-2.1%-4,829-4,729-4,428-1,904-1,722
  Additional Paid-In Capital0.9%4,9314,8894,8154,7494,701
Accumulated Depreciation25.5%75.0060.0054.0048.00-
Shares Outstanding3.2%246238232228228
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations16.0%-492-586-623-617-559
  Share Based Compensation-6.3%199213178168180
Cashflow From Investing-38.5%-174-126-190-379-204
Cashflow From Financing-78.5%2.008.009.001,1291,566

Risks for NVTA

What is the probability of a big loss on NVTA?

100%


Probability that Invitae stock will be more than 20% underwater in next one year

100%


Probability that Invitae stock will be more than 30% underwater in next one year.

86.5%


Probability that Invitae stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NVTA drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Invitae was unfortunately bought at previous high price.

Drawdowns

Returns for NVTA

Cumulative Returns on NVTA

-24.1%


7-Year Cumulative Returns

-28.7%


5-Year Cumulative Returns

-52.6%


3-Year Cumulative Returns

What are the long-term rolling returns for NVTA?

FIve years rolling returns for Invitae.

Annualized Returns

Which funds bought or sold NVTA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-68.58
-156,329
48,671
-%
2023-03-10
BAILLIE GIFFORD & CO
unchanged
-
-512
1,488
-%
2023-03-06
Rockefeller Capital Management L.P.
reduced
-96.14
-3,000
-
-%
2023-03-02
OLIVER LAGORE VANVALIN INVESTMENT GROUP
unchanged
-
93.00
93.00
-%
2023-02-28
Voya Investment Management LLC
added
5.89
-44,317
179,683
-%
2023-02-21
MACQUARIE GROUP LTD
sold off
-100
-9,000
-
-%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
added
188
134
134
-%
2023-02-16
AXXCESS WEALTH MANAGEMENT, LLC
reduced
-28.71
-53,929
63,071
-%
2023-02-16
HARBOUR INVESTMENTS, INC.
unchanged
-
372
372
-%
2023-02-15
Seaport Global Advisors, LLC
reduced
-41.39
-42,893
34,107
0.12%

1–10 of 42

Latest Funds Activity

Are funds buying NVTA calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own NVTA
No. of Funds

Invitae News

Marketing Sentinel

Invitae Corporation (NYSE: NVTA) Shocks Wall Street This Week ....

Marketing Sentinel,
3 hours ago

InvestorsObserver

Marketscreener.com

InvestorsObserver

Nanalyze

InvestorsObserver

InvestorsObserver

Schedule 13G FIlings of Invitae

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
casdin capital, llc
3.72%
9,038,388
SC 13G/A
Feb 09, 2023
vanguard group inc
9.30%
22,587,955
SC 13G/A
Feb 03, 2023
sumitomo mitsui trust holdings, inc.
7.10%
17,256,161
SC 13G/A
Jan 25, 2023
blackrock inc.
9.0%
21,768,046
SC 13G
Feb 14, 2022
baker bros. advisors lp
4.4%
9,873,488
SC 13G/A
Feb 14, 2022
nikko asset management americas, inc.
8.39%
18,998,453
SC 13G/A
Feb 14, 2022
casdin capital, llc
5.39%
12,203,669
SC 13G/A
Feb 09, 2022
ark investment management llc
11.80%
26,700,813
SC 13G/A
Feb 04, 2022
sumitomo mitsui trust holdings, inc.
8.39%
18,998,453
SC 13G/A
Feb 03, 2022
blackrock inc.
7.7%
17,484,785
SC 13G/A

NVTA Fair Value

Invitae fair value in different scenarios

The table shows the Fair Value estimates for Invitae for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

0.23

-82.17%

1.23

-4.65%

3.09

139.53%

6.84

430.23%
Current Inflation

0.02

-98.45%

0.17

-86.82%

1.05

-18.60%

2.65

105.43%

5.86

354.26%
Very High Inflation

-

-

0.10

-92.25%

0.83

-35.66%

2.14

65.89%

4.73

266.67%

Historical Invitae Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Invitae

View All Filings
Date Filed Form Type Document
Mar 17, 2023
S-3
S-3
Mar 15, 2023
4
Insider Trading
Mar 15, 2023
4
Insider Trading
Mar 15, 2023
4
Insider Trading
Mar 15, 2023
4
Insider Trading
Mar 14, 2023
8-K
Current Report
Mar 08, 2023
8-K
Current Report
Mar 01, 2023
8-K
Current Report
Mar 01, 2023
POS AM
POS AM
Mar 01, 2023
POS AM
POS AM

Latest Insider Trading transactions for NVTA

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-13
Nussbaum Robert L
sold
-3,701
1.41
-2,625
chief medical officer
2023-03-13
Wen Yafei
sold
-3,701
1.41
-2,625
chief financial officer
2023-03-13
Knight Kenneth D.
sold
-2,612
1.41
-1,853
chief executive officer
2023-03-13
Brida Thomas
sold
-3,701
1.41
-2,625
see remarks
2023-01-26
Osborne William H
acquired
-
-
70,423
-
2022-12-19
George Sean E
sold
-23,210
2.0792
-11,163
-
2022-12-16
George Sean E
sold
-91,420
2.0399
-44,816
-
2022-08-25
WERNER ROBERT F.
sold
-4,657
3.45
-1,350
chief accounting officer
2022-08-22
Nussbaum Robert L
acquired
-
-
54,000
chief medical officer
2022-08-22
Wen Yafei
acquired
-
-
102,000
chief financial officer

1–10 of 50

Sean E. George
3000
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

NVTA Income Statement

2022-12-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue:   
Total revenue$ 516,303$ 460,449$ 279,598
Operating expenses:   
Cost of revenue417,256348,669198,275
Research and development402,088416,087240,605
Selling and marketing218,881225,910168,317
General and administrative192,314248,070270,029
Goodwill and IPR&D impairment2,313,04700
Restructuring and other costs140,33100
Gain on sale of RUO kit assets(47,354)00
Change in fair value of contingent consideration(1,850)(386,646)54,544
Total operating expenses3,634,713852,090931,770
Loss from operations(3,118,410)(391,641)(652,172)
Other income (expense), net:   
Change in fair value of acquisition-related liabilities15,90625,196(37,527)
Other income, net8,0544825,195
Total other income (expense), net23,96025,678(32,332)
Interest expense(56,747)(49,900)(29,766)
Net loss before taxes(3,151,197)(415,863)(714,270)
Income tax benefit44,90436,857112,100
Net loss$ (3,106,293)$ (379,006)$ (602,170)
Net loss per share, basic (in dollars per share)$ (13.18)$ (1.80)$ (4.47)
Net loss per share, diluted (in dollars per share)$ (13.18)$ (1.80)$ (4.47)
Shares used in computing net loss per share, basic (in shares)235,676,000210,946,000134,587,000
Shares used in computing net loss per share, diluted (in shares)235,676,000210,946,000134,587,000
Test revenue   
Revenue:   
Total revenue$ 500,560$ 444,072$ 272,310
Data/services   
Revenue:   
Total revenue$ 15,743$ 16,377$ 7,288

NVTA Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 257,489$ 923,250
Marketable securities289,611122,121
Accounts receivable96,14866,227
Inventory30,38633,516
Prepaid expenses and other current assets19,49633,691
Total current assets693,1301,178,805
Property and equipment, net108,723114,714
Operating lease assets106,563121,169
Restricted cash10,03010,275
Intangible assets, net1,012,5491,187,994
Goodwill02,283,059
Other assets23,12123,551
Total assets1,954,1164,919,567
Current liabilities:  
Accounts payable13,98421,127
Accrued liabilities74,388106,453
Operating lease obligations14,60012,359
Finance lease obligations5,1214,156
Total current liabilities108,093144,095
Operating lease obligations, net of current portion134,386124,369
Finance lease obligations, net of current portion3,7805,683
Debt122,333113,391
Convertible senior notes, net1,470,7831,464,138
Deferred tax liability8,13051,696
Other long-term liabilities4,77537,797
Total liabilities1,852,2801,941,169
Commitments and contingencies (Note 8)
Preferred stock, $0.0001 par value: 20,000 shares authorized; nil shares issued and outstanding as of December 31, 2022 and 2021, respectively00
Stockholders’ equity:  
Common stock, $0.0001 par value: 600,000 and 400,000 shares authorized; 245,562 and 228,116 shares issued and outstanding as of December 31, 2022 and 2021, respectively2523
Accumulated other comprehensive loss(80)(7)
Additional paid-in capital4,931,0324,701,230
Accumulated deficit(4,829,141)(1,722,848)
Total stockholders’ equity101,8362,978,398
Total liabilities and stockholders’ equity$ 1,954,116$ 4,919,567